Welcome to CDC Stacks | Genome-wide association studies in pharmacogenomics: untapped potential for translation - 3992 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Genome-wide association studies in pharmacogenomics: untapped potential for translation
  • Published Date:
    Apr 28 2009
  • Source:
    Genome Med. 2009; 1(4):46.
Filetype[PDF - 103.61 KB]


Details:
  • Description:
    Despite large public investments in genome-wide association studies of common human diseases, so far, few gene discoveries have led to applications for clinical medicine or public health. Genome-wide association studies in the context of clinical trials of drug safety and efficacy may be quicker to yield clinical applications. Certain methodological concerns, such as selection bias and confounding, may be mitigated when genome-wide association studies are conducted within clinical trials, in which randomization of exposure, prospective evaluation of outcome and careful definition of phenotype are incorporated by design.

  • Document Type:
  • Collection(s):
No Related Documents.
You May Also Like: